First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium.

Published

Conference Paper

Universities Allied for Essential Medicines organized its first Neglected Diseases and Innovation Symposium to address expanding roles of public sector research institutions in innovation in research and development of biomedical technologies for treatment of diseases, particularly neglected tropical diseases. Universities and other public research institutions are increasingly integrated into the pharmaceutical innovation system. Academic entities now routinely undertake robust high-throughput screening and medicinal chemistry research programs to identify lead compounds for small molecule drugs and novel drug targets. Furthermore, product development partnerships are emerging between academic institutions, non-profit entities, and biotechnology and pharmaceutical companies to create diagnostics, therapies, and vaccines for diseases of the poor. With not for profit mission statements, open access publishing standards, open source platforms for data sharing and collaboration, and a shift in focus to more translational research, universities and other public research institutions are well-placed to accelerate development of medical technologies, particularly for neglected tropical diseases.

Full Text

Duke Authors

Cited Authors

  • Musselwhite, LW; Maciag, K; Lankowski, A; Gretes, MC; Wellems, TE; Tavera, G; Goulding, RE; Guillen, E

Published Date

  • January 2012

Published In

Volume / Issue

  • 86 / 1

Start / End Page

  • 65 - 74

PubMed ID

  • 22232453

Pubmed Central ID

  • 22232453

Electronic International Standard Serial Number (EISSN)

  • 1476-1645

International Standard Serial Number (ISSN)

  • 0002-9637

Digital Object Identifier (DOI)

  • 10.4269/ajtmh.2012.11-0608